Company Overview - Dentsply Sirona is led by CEO Dan Scavilla, who joined the company five months ago after a successful tenure at Globus Medical, where he helped grow revenue from $300 million to $3 billion [2] - Scavilla has extensive experience in the healthcare sector, having spent 28 years at Johnson & Johnson, which provided him with insights into various business models applicable to the current healthcare environment [3] Strategic Focus - The company emphasizes the strength of its brands and customer loyalty, which are seen as key assets in shaping the future of dentistry and connected dentistry [4] - Dentsply Sirona has an integrated portfolio that positions it well to influence advancements in the dental industry [4]

R&D was repeatedly characterized as central to the company’s approach. Montag said Siemens Healthineers invests about €2 billion in R&D and employs 13,000 R&D staff , describing the company as a leader in AI for its field. He also referenced “physical AI,” describing AI algorithms tightly integrated with hardware to accelerate image acquisition and improve image quality.Montag highlighted a focus on non-communicable diseases such as cancer and cardiovascular disease, arguing that the future of care requires ...

Avanos Medical (NYSE:AVNS) FY Conference January 13, 2026 05:15 PM ET Company ParticipantsDave Pacitti - CEOJalanjith Timmy - AssociateJalanjith TimmyGood afternoon, everyone, and thank you for joining us this week at the J.P. Morgan Healthcare Conference. Great to have you all this afternoon join us. My name is Jalankith Timmy, and I'm an associate on the JPMorgan Healthcare team. Today, it is my pleasure to introduce Avanos Medical. Joining us for today's presentation is Dave Pacitti, CEO of Avanos, and S ...

Kestra Medical Technologies (NasdaqGS:KMTS) FY Conference January 13, 2026 05:15 PM ET Company ParticipantsBrian Webster - CEOConference Call ParticipantsRobbie Marcus - MedTech AnalystRobbie MarcusGood afternoon, everyone. I'm Robbie Marcus, the MedTech analyst at JPMorgan. Happy to bring up CEO of Kestra, Brian Webster. He's going to do a presentation, then we'll do some Q&A after.Brian WebsterSounds good. Thanks, Robbie. OK, thanks, Robbie. Hello, everyone. Good afternoon. You guys are coming up on midpo ...

Siemens Healthineers AG J.P. Morgan Healthcare Conference, January 13, 2026 Unrestricted © Siemens Healthineers, 2026 Unrestricted © Siemens Healthineers, 2025 This webcast has been provided solely for use at this meeting. By attending the meeting or accessing this webcast, you agree to be bound by the following limitations. This webcast is provided in conjunction with an oral presentation and should not be taken out of context. This webcast serves for information purposes only and the information contained ...

These statements are subject to risks and uncertainties that could cause our actual results to differ materially from those expressed or implied in such statements, including risks related to changes in the competitive environment; market demand and pricing pressure; cost containment measures that could adversely affect the price of or demand for our products; raw material, energy, and other input costs; supply chain disruptions (including availability of drugs used in our Surgical Pain and Recovery product ...

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (NASDAQ: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocadâ"¢ CAD/CAM software for digital orthodontics and restorative dentistry, today announced a new initiative with the Canadian Foundation for the Advancement of Orthodontics (CFAO). Under this initiative, Align has committed to support Invisalign treatment for 30 eligible pati. ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

Group 1 - The presentation is led by Ivan Tornos, who is the President, CEO, and Chairman of the Board of Zimmer Biomet [1] - The company aims to summarize its presentation quickly to accommodate the busy schedule of the audience, which includes numerous presentations over the next few days [2] - Zimmer Biomet expresses satisfaction with the progress made over the last five years, indicating a positive outlook for the company in 2026 [3]

J.P. Morgan 44th Annual Healthcare Conference failure to retain key suppliers; challenges to the future development of our non-insulin drug delivery product line; our failure or that of our contract manufacturer or component suppliers to comply with the U.S. Food and Drug Administration's quality system regulations or other manufacturing difficulties; extensive government regulation applicable to medical devices, as well as complex and evolving privacy and data protection laws; our use of artificial intelli ...